With reference to its earlier Press Release of August 6, 2021 titled ‘Strides inks definitive agreement with Endo to acquire its manufacturing facility in the US along with basket of ANDAs’. With reference to above, Strides Pharma Science has informed that the transaction has now achieved closure.
The above information is a part of company’s filings submitted to BSE.